The CFAR/CSG Clinical Core will provide a mechanism for multidisciplinary collaboration among basic, clinical and behavioral scientistic to address innovative research questions important to a better understanding of HIV disease pathogenesis or better methods of diagnosis or treatment of HIV disease. Specifically, this Core will facilitate translation between basic and clinical HIV research by providing 1) expert clinical research consultation to assist basic scientists in developing the most appropriate protocol design for testing their specific hypotheses, 2) experienced clinical research staff personnel to recruit subjects and implement protocols thus providing basic scientists in developing the most appropriate specimens needed for specific hypothesis testing, 3) behavioral expertise to basic scientists and clinical researchers to assist them in conceptualizing and implementing research protocols and interpreting findings, and 4) behavioral scientists the opportunity to test hypotheses relevant to behavioral research questions in clinical populations. The expert clinical consultation service includes an associate professor of medicine infectious diseases/clinical trials specialist a research pharmacist/coordinator, an associate professor of biostatistics, who will serve as coordinator of the Behavioral Research Unit within in the Clinical Core, each with 8 or more years of academic, HIV-related clinical research experience at UCSF. The Core Director and Research Coordinator already coordinate a dynamic HIV clinical research program as San Francisco General Hospital that is integrated into an outpatient clinic with a patients base of greater than 3,000 individuals at various stages of HIV disease. The Core Director, Study Coordinator and scientists in the Behavioral Research Unit already collaborate on a number of multidisciplinary studies to test specific hypotheses that emerge from basic research. The full Clinical Core service will provide consultation with the investigators to determine optimal study design, preparation of a written study protocol and subjects informed consent form, obtaining IRB approval and ;maintaining required IRBG correspondence for the protocol, recruitment of subjects, obtaining and providing investigator with all protocol-specific specimens are relevant clinical data, long-term storage of specimens in an ultra-low temperature specimen repository, and behavioral assessments. These services will enable different investigators, and multidisciplinary teams of investigators, to efficiently explore innovative hypotheses, ranging from clinical studies of the molecular biology of HIV to behavioral studies of cofactors in treatment response among women and minorities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH059037-13
Application #
6302657
Study Section
Project Start
2000-03-15
Project End
2001-02-28
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
13
Fiscal Year
2000
Total Cost
$349,258
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Josefsson, Lina; von Stockenstrom, Susanne; Faria, Nuno R et al. (2013) The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc Natl Acad Sci U S A 110:E4987-96
Josefsson, Lina; Eriksson, Susanne; Sinclair, Elizabeth et al. (2012) Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA. J Infect Dis 206:28-34
Papasavvas, Emmanouil; Hsue, Priscilla; Reynolds, Griffin et al. (2012) Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjects. Antivir Ther 17:557-63
Hunt, Peter W; Landay, Alan L; Sinclair, Elizabeth et al. (2011) A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One 6:e15924
Hunt, Peter W; Hatano, Hiroyu; Sinclair, Elizabeth et al. (2011) HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers. Clin Infect Dis 52:681-7
Hunt, Peter W; Cao, Huyen L; Muzoora, Conrad et al. (2011) Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS 25:2123-31
Kitchen, Christina M R; Yeghiazarian, Lilit; Hoh, Rebecca et al. (2011) Immune activation, CD4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infection. PLoS One 6:e21190
Favre, David; Stoddart, Cheryl A; Emu, Brinda et al. (2011) HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells. Blood 117:2189-99
Hunt, Peter W; Martin, Jeffrey N; Sinclair, Elizabeth et al. (2011) Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis 203:1474-83
Favre, David; Mold, Jeff; Hunt, Peter W et al. (2010) Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2:32ra36

Showing the most recent 10 out of 157 publications